Company Filing History:
3 out of 5,094 
1 out of 112 
1 out of 215 
Years Active: 2013-2019
Title: Anne Imberty: Innovator in Glycobiology
Introduction
Anne Imberty is a prominent inventor based in Claix, France. She has made significant contributions to the field of glycobiology, particularly in the development of lectins and glycomimetic compounds. With a total of 3 patents, her work has implications for medical diagnostics and treatments.
Latest Patents
Among her latest patents is a groundbreaking invention titled "Lectins and applications for the detection of pathological state markers." This patent focuses on multimenic lectins with a β-propeller architecture, which are formed from monomer modules of approximately 30 to 60 amino acids. The binding sites to the glycans are strategically located on one side of the proteins, while the peptide chain ends are positioned on the opposite side. Another notable patent is for "Glycomimetic compounds as anti-infectious against pathogens lectins." This invention describes a calixarene-based glycosylated compound that can be used in pharmaceutical compositions to prevent or treat bacterial infections that utilize lectins during the initial stages of infection.
Career Highlights
Anne has worked with esteemed institutions such as the Centre National de la Recherche Scientifique and Université Joseph Fourier. Her research has been pivotal in advancing the understanding of glycan interactions and their applications in medicine.
Collaborations
Throughout her career, Anne has collaborated with notable colleagues, including Aymeric Audfray and Julie Arnaud. These partnerships have enriched her research and contributed to her innovative work in glycobiology.
Conclusion
Anne Imberty's contributions to the field of glycobiology through her patents and collaborations highlight her role as a leading inventor. Her work continues to pave the way for advancements in medical diagnostics and treatments.